A plastic-surgery device maker is riding rising demand as more surgeons in the U.S. adopt its implants and newer, less invasive options, helped along by social media and shifting attitudes. The upside hinges on keeping its growth going overseas and reining in heavy spending while competitors push back.Read more
Establishment Labs says growing demand for cosmetic and reconstructive surgery could push its Motiva implants and newer, less invasive procedures into the mainstream faster than many expect, especially in the U.S. But the story depends on staying ahead of regulators, managing cash needs, and holding up against shifting consumer tastes and non-surgical alternatives.Read more
Establishment Labs sells implants used in cosmetic and reconstructive surgery, but shifting attitudes and tougher rules around plastics could make these procedures less popular and harder to sell over time. The story hinges on whether new products and strong growth in key markets can keep demand rising before competition and higher compliance costs squeeze profits.Read more
No trending discussion available.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
